Figure in the Supporting Information shows box plots and summary statistics of the distribution of the six calculated properties of pharmaceutical relevance. The profiling of the six properties indicated that, in general, all 11 compound libraries are within the Lipinski and Veber parameters. Based on this criterion, the libraries are acceptable candidate compounds for drug discovery and development programs (in particular, to be administered orally). All 11 compound data sets have a comparable distribution of the six properties, as shown in Figure . The outcome of the profiling might be anticipated since it is likely that the chemical vendors (developers) filter or consider the so-called "drug-like" properties during the assembly of the focused libraries. However, the profiling disclosed in this work is relevant and encourages the experimental screening of the 11 compound libraries for drug discovery projects.